AbbVie
ABBV
S$246.44
Share price
-1.31%
Change (1 day)
9.21%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Stock price history for AbbVie (ABBV)
Highest end of day price: S$277.44 SGD on 2025-03-10
Lowest end of day price: S$43.17 SGD on 2013-01-08
Stock price history of AbbVie from 2013 to 2025
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2025 | 7.25% |
| 2024 | 11.19% |
| 2023 | -4.56% |
| 2022 | 19.34% |
| 2021 | 28.45% |
| 2020 | 19.65% |
| 2019 | -0.77% |
| 2018 | -6.32% |
| 2017 | 54.96% |
| 2016 | 8.70% |
| 2015 | -10.09% |
| 2014 | 25.89% |
| 2013 | 50.37% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Pfizer PFE | S$32.85 | -0.50% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$60.01 | -3.42% | 🇺🇸 USA |
 Eli Lilly LLY | S$1,015 | 0.30% | 🇺🇸 USA |
 Amgen AMGN | S$378.11 | -1.70% | 🇺🇸 USA |
 Gilead Sciences GILD | S$140.40 | -4.28% | 🇺🇸 USA |
 Biogen BIIB | S$171.86 | -0.83% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$49.02 | -3.28% | 🇬🇧 UK |
 AstraZeneca AZN | S$91.08 | -0.95% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | S$170.90 | -1.08% | 🇺🇸 USA |